# Bioequivalence Study of Zolpidem Tartrate Tablets and Ambien® Under Fasting Conditions

> **NCT00684814** · PHASE1 · COMPLETED · sponsor: **Mutual Pharmaceutical Company, Inc.** · enrollment: 38 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Zolpidem Tartrate 10 mg tablet
- **DRUG:** Zolpidem Tartrate 10 mg tablet (Ambien®)

## Key facts

- **NCT ID:** NCT00684814
- **Lead sponsor:** Mutual Pharmaceutical Company, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2004-05
- **Final completion:** 2004-05
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2012-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00684814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00684814, "Bioequivalence Study of Zolpidem Tartrate Tablets and Ambien® Under Fasting Conditions". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00684814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*